Previous close | 137.90 |
Open | 138.70 |
Bid | 140.30 x 0 |
Ask | 140.40 x 0 |
Day's range | 138.70 - 138.70 |
52-week range | 102.70 - 138.70 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
AptarGroup Inc (NYSE:ATR), a company specializing in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active material science solutions, recently saw a significant insider transaction.
AptarGroup (ATR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Silgan's (SLGN) first-quarter top and bottom lines reflect the impacts of lower volumes owing to customer destocking.